Cancer Prevention Research

Aims & Scope

Cancer Prevention Research publishes original studies, reviews, and perspectives in the field of cancer prevention.

Its scope includes the molecular and cellular biology of premalignancy and early lesions; genetic and environmental risk factors; risk assessment and reduction; early detection research (cancer screening and diagnosis); and preventive interventions (chemoprevention, immunoprevention, and others) to intercept cancer development at early stages prior to initiation, promotion, or progression.

The journal comprises preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.6
2024	2.90

Journal Rank

Year	Value
2024	2921

Journal Citation Indicator

Year	Value
2024	786

SJR (SCImago Journal Rank)

Year	Value
2024	1.342

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	115

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis

  Citation: 740

  Authors: Andrea, Matteo, Pamela, Massimiliano, Alessandra, Bernardo, Sara

• Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies

  Citation: 733

  Authors: Colin C., Evan, Brent, Jason D., Katy J., Melanie M., Jonathan F., Muneesh

• Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer

  Citation: 529

  Authors: Victor G., Joseph P., D. Lawrence, Walter M., Reena S., James N., Therese B., Louis, Eduardo R., James L., André, Richard G., Joan, Carolyn D., Patricia A., Steven E., Worta, Leslie G., V. Craig, Norman

• The Human Gut Microbiome as a Screening Tool for Colorectal Cancer

  Citation: 458

  Authors: Joseph P., Mary A.M., Mack T., Patrick D.

• MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease

  Citation: 438

  Authors: Jin, Jinyun, Ping, Aimee, Donghui, James L., Marsha L., Ann M., Subrata

• Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia

  Citation: 426

  Authors: Robert E., Richard V., Danielle Kim, Shaiju, Malloree, Luz, Madhuri, Philip M., Christine, Frank L., Dean E.

• Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials

  Citation: 425

  Authors: Anupam

• Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial

  Citation: 421

  Authors: Frank L., Christine E., Daniel, Sharon, Philip M., Ernest, Gary, Michael J., Jayashri, John, C. Gregory, Dennis J., D. Kim, Steven, Peter, Curt H., Daniel L., Eugene W.

• Body Mass Index, Prostate Cancer–Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis

  Citation: 401

  Authors: Yin, Jing

• Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer

  Citation: 386

  Authors: Patrick G., Clifford A., Dilip, Monica, Domenick J., Xi Kathy, Baoheng, Edi, Carolyn B., Levy, Kotha, Andrew J.

---